Cleared Traditional

K823005 - BIO MAG FREE T4 RADIOIMMUNOASSAY KIT

K823005 is the FDA 510(k) clearance for BIO MAG FREE T4 RADIOIMMUNOASSAY KIT by Bioclinical Group. It is a Class 2 Chemistry device (product code CEC) cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K823005 · Bioclinical Group · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1982
Decision
64d
Days
Class 2
Risk

K823005 is an FDA 510(k) clearance for the BIO MAG FREE T4 RADIOIMMUNOASSAY KIT. Classified as Radioimmunoassay, Free Thyroxine (product code CEC), Class II - Special Controls.

Submitted by Bioclinical Group (Walker, US). The FDA issued a Cleared decision on December 15, 1982 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1695 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bioclinical Group devices

Submission Details

510(k) Number K823005 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 12, 1982
Decision Date December 15, 1982
Days to Decision 64 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 88d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEC Radioimmunoassay, Free Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1695
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEC Radioimmunoassay, Free Thyroxine

All 66
Devices cleared under the same product code (CEC) and FDA review panel - the closest regulatory comparables to K823005.
AMERLEX-M FREE T-4 RADIOIMMUNOASSAY KIT
K842482 · Amersham Corp. · Aug 1984
CORNING MAGIC SINGLE STEP FREE T4
K832381 · Corning Medical & Scientific · Sep 1983
THYROXINE ANALYSIS PRODUCTS/RADIO-FREE
K823264 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jan 1983
SINGLE STEP FREE-T4 125I RADIOIMMUNO-
K823144 · Corning Medical & Scientific · Nov 1982
COAT-A-COUNT FREE THYROXINE KIT/COMPONEN
K822882 · Diagnostic Products Corp. · Nov 1982
FREE T4 RIA TEST SET
K813465 · Ventrex Laboratories, Inc. · Dec 1981